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Abstract 
Objective: Administration of amoxicillin and metronidazole along with scaling and root planning 
(SRP) is an effective adjunctive therapy for chronic periodontitis. Studies have shown that 
administration of azithromycin is also effective for treatment of chronic periodontitis. This study 
aimed to compare the effect of short-term and long-term azithromycin regimen with amoxicillin and 
metronidazole for treatment of moderate chronic periodontitis in adults. 
Methods: This experimental study was carried out on 75 patients with moderate chronic 
periodontitis aged 35-50 yrs. with at least one pocket with a probing depth of 4-6 mm and 
attachment loss of 3-4 mm in each quadrant. Loe and Silness Gingival Index (GI), Modified 
Papillary Bleeding Index (MPBI) of Barnett, Loe and Silness Plaque Index (PLI), Probing Pocket 
Depth (PPD) and Attachment Loss (AL) were calculated at 0, 2 and 4 days, 6 weeks and 2 and 3 
months after therapy. The patients underwent SRP and assigned to three groups. Group one received 
250 mg metronidazole plus 250 mg amoxicillin 3 times a day for 7 days. Group 2 received 500 mg 
azithromycin twice daily for 7 days and group 3 received 250 mg azithromycin once a day for one 
month. Data were analyzed using ANOVA and Repeated Measures ANOVA.  
Results: PLI, MPBI, GI, PPD and AL parameters showed a significant reduction in all groups at all 
understudy time points (p<0.05). The reduction in BI, GI and PLI parameters was greater in group 3 
compared to groups 1 and 2 (p <0.05); but, no significant difference was observed between groups 1 
and 2 in this respect. A greater reduction in PPD was noted in groups 2 and 3 compared to group 1  
(p<0.05). AL showed a significant reduction in group 3 compared to groups 1 and 2 only in the final 
follow-up session (p =0.042). 
Conclusion: Antibiotic therapy regimens were all effective for treatment of chronic periodontitis but 
the magnitude of improvement was greater in long-term azithromycin group compared to others. 
Key words: Adjunctive periodontal therapy, Amoxicillin, Chronic periodontitis, Long-term 
azithromycin, Metronidazole, Short-term azithromycin.  
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Chronic periodontitis is the most common form 
of periodontitis causing bone loss and 
attachment loss. This disease has a slow 
progression and is more prevalent in adults (1). 
Calculus and bacterial plaque are among the 
etiologic factors; thus, treatment is mainly 
comprised of removal of supra- and sub-gingival 
calculus to reduce bacterial content. However, 
despite this treatment, progressive attachment 
loss continues in some patients indicating that 
mechanical treatment is not successful in 
reducing some periodontal pathogens. Therefore, 
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antibiotic therapy is recommended to reduce the 
number of these resistant pathogens (2). 
Metronidazole-amoxicillin regimen is an 
effective systemic antibiotic therapy for chronic 
periodontitis (3, 4). Metronidazole is a 
bactericidal antibiotic effective against 
anaerobes (3). Amoxicillin belongs to penicillin 
family and has a broad-spectrum of action 
against gram-positive and gram-negative 
bacteria (3). MoeinTaghavi et al. in 2007 
reported a significantly greater improvement in 
patients subjected to 7 days of treatment with 
metronidazole-amoxicillin regimen compared to 
the control group receiving placebo (2). Rooney 
et al. in 2002 compared the therapeutic effects of 
metronidazole-placebo (MP), amoxicillin-
placebo (AP), metronidazole-amoxicillin (AM) 
and placebo alone (PP). The best results were 
obtained in the AM group. Also, the results of 
AP and MP groups were better than PP (4). 
Kaner et al. in 2007 showed that in adults with 
generalized aggressive periodontitis, treatment 
with metronidazole-amoxicillin was associated 
with more favorable clinical outcome compared 
to chlorhexidine chips (5). Valenza et al. in 2009 
stated that combination of metronidazole-
amoxicillin was effective for treatment of 
chronic periodontitis but its effect on some 
bacterial strains was transient (6). 
In the recent years, due to higher patient 
compliance tomono-drug regimens and lower 
frequency of drug intake per day, use of 
azithromycin for treatment of periodontitis has 
attracted some attention. Azithromycin is a 
macrolide effective against anaerobes and gram-
negative bacilli. Furthermore, its therapeutic 
effects remain for a long time after drug intake 
in the gingival crevicular fluid. Thus, it may be 
administered along with SRP and after it for 
treatment of periodontitis (3). Gomi et al. in 
2007 evaluated the effective concentration of 
azithromycin in the gingival crevicular fluid and 
demonstrated that after a 3-day treatment course, 
drug concentration was still effectively high in 
gingival crevicular fluid and lasted until day 14 
(7). 
Considering the fact that azithromycin can be 
administered as monotherapy and several studies 
have shown the long-lasting presence of its 
therapeutic concentrations in the gingival sulcus, 
the present study aimed to evaluate the effect of 
long-term azithromycin regimen on patients with 
chronic periodontitis and compare it with short-
term azithromycin and metronidazole-




This experimental study was conducted on 75 
patients aged 35-50 yrs. presenting to the 
Periodontology Department of Babol University 
of Medical Sciences, School of Dentistry. 
Patients were selected by non-randomized 
convenient sampling. The study design was 
approved in the Ethics Committee of Babol 
University of Medical Sciences. The inclusion 
criteria were suffering from moderate chronic 
adult periodontitis with at least one pocket with 
4-6 mm depth and 3-4 mm attachment loss in 
each quadrant. The exclusion criteria were 
smoking, systemic diseases, drug intake and 
periodontal abscess. PPD, PLI, MPBI, GI and 
AL were measured in patients’ Ramfjord teeth 
(8). After obtaining a written informed consent 
from patients, Bass technique of brushing was 
instructed to patients to create a reference index 
and eliminate the confounding effect of PLI. 
Patients were provided with Oral B toothbrush 
and Crest toothpaste. After two weeks, patients 
were visited again and if their PI was less than 
30%, they entered the study. The mentioned 
indexes were once again measured and patients 
received SRP. Patients were non-randomly 
assigned to 3 groups receiving different 
antibiotic regimens. Patients in group 1 
comprised 12 females and 13 males with a mean 
age of 43.7 yrs. and received 250 mg 
metronidazole (Tehran Chimie Pharmaceutical 
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Co., Tehran, Iran) and 250 mg amoxicillin 
(Kosar Pharmaceuticals, Tehran, Iran) 3 times a 
day for 7 days. The second group included 11 
females and 14 males with a mean age of 42.5 
yrs. and received 500 mg azithromycin (Farabi 
Pharmaceuticals, Tehran, Iran) twice a day for 7 
days. Group 3 comprised 11 females and 14 
males with a mean age of 40.9 yrs. and received 
250 mg azithromycin (Tolid Daru, Co., Tehran, 
Iran) once a day for one month. At 2, 4 and 6 
weeks and 2 and 3 months the mentioned 
clinical parameters were measured again in 
patients’ Ramfjord teeth. Obtained data were 
compared between different groups using 




Table 1 shows the PLI values in understudy 
groups at different time points. 
 
Table 1- The mean and standard deviation of PLI in the understudy groups at different time points 














Met-Amoxi (1) 1.13 (0.32) 0.56 (0.13) 0.5 (0.11) 0.57 (0.12) 0.57 (0.14) 0.57 (0.13) 0.63 (0.18) 
Az short (2) 0.13 (0.39) 0.53 (0.08) 0.55 (0.09) 0.58 (0.103) 0.55 (0.07) 0.6 (0.12) 0.64 (0.11) 
Az long (3) 1.3 (0.35) 0.44 (0.11) 0.38 (0.14) 0.38 (0.12) 0.45 (0.14) 0.44 (0.17) 0.41 (0.15) 
 
At all time points, a significant difference was 
noted between the long-term azithromycin and 
metronidazole-amoxicillin and short-term 
azithromycin groups (p<0.05). But no significant 
difference was found between the 
metronidazole-amoxicillin and short-term 
azithromycin. Significant differences were found 
between different groups at different time points 
(p<0.0001 for intragroup and p<0.001 for inter-
group comparisons). A significant reduction was 
observed in PLI in long-term azithromycin 
compared to metronidazole-amoxicillin and 
short-term azithromycin groups (0.89±0.39 
versus 0.50± 0.34 and 0.49±0.43, respectively; 
p>0.0001). According to the results of Table 2, 
no significant difference was found in GI 
between different groups at the onset of 
treatment and 2 weeks post-therapy. However, at 
2 months, a significant difference was noted 
between the two groups of metronidazole-
amoxicillin and short-term azithromycin 
(p<0.05). Furthermore, according to the results 
of Repeated Measures ANOVA, significant 
differences existed between different groups and 
also within groups at different time points 
(P<0.0001 for intragroup and p<0.006 for 
intergroup comparisons). A significant reduction 
was also observed in GI in long-term 
azithromycin group compared to metronidazole-
amoxicillin and short-term azithromycin groups 
(0.90(0.35) versus 0.66(0.32) and 0.60(0.38), 
respectively; p=0.011). 
 
Table 2- The mean and standard deviation of GI in the understudy groups at different time points 














Met-Amoxi (1) 1.4 (0.22) 1.3 (0.3) 0.9 (0.16) 0.8 (0.17) 0.8 (0.19) 0.8 (0.21) 0.7 (0.26) 
Az short (2) 1.22 (0.32) 1.17 (0.19) 0.86 (0.14) 0.75 (0.13) 0.7 (0.15) 0.61 (0.15) 0.62 (0.17) 
Az long (3) 0.34 (0.27) 1.34 (0.32) 0.75 (0.28) 0.65 (0.24) 0.53 (0.16) 0.49 (0.21) 0.43 (0.22) 
 
MPBI (Diagram 1), at 2 weeks after treatment in 
long-term azithromycin group was significantly 
different than in short-term azithromycin and 
metronidazole-amoxicillin groups (p<0.0001 for 
both). However, this parameter was not 
significantly different at initiation of treatment 
and at 4 and 6 weeks. At 2 months post-
treatment, a significant difference was only 
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detected between the two groups of short-term 
and long-term azithromycin (p<0.048) and at 3 
months, the differences between all three groups 
were statistically significant in this regard 
(p<0.05). 
 
Diagram 1- The mean MPBI in understudy 
groups at different time points 
 
According to Repeated Measures ANOVA, 
MPBI values were significantly different 
between the understudy groups at different time 
points (p<0.0001 for intragroup and p<0.006 for 
inter-group comparisons). A greater reduction 
was observed in MPBI in long-term 
azithromycin group than in metronidazole-
amoxicillin and short-term azithromycin groups 
(0.78(0.37) versus 0.36(0.29) and 0.37(0.19), 
respectively; p>0.0001). As presented in 
Diagram 2, PPD was not significantly different 
at 2 and 3 months. A significant difference was 
noted in this parameter at the initiation of 
treatment and at 2 and 4 weeks between the 
metronidazole-amoxicillin group and short-term 
and long- term azithromycin groups (p<0.05). At 
6 weeks, a significant difference was found only 
between metronidazole-amoxicillin and long-
term azithromycin groups (p<0.05). 
According to the results of Repeated Measures 
ANOVA, significant differences existed in PPD 
values between different groups and within each 
group at different time points (p<0.0001 for 
intragroup and p<0.005 for inter-group 
comparisons; p<0.005). Reduction in PPD was 
0.43(0.34), 0.24(0.23) and 0.41(0.15) in long-
term azithromycin, metronidazole-amoxicillin 




Diagram 2- The mean PPD in the understudy 




Diagram 3-The mean AL in understudy groups at 
different time points 
 
According to the results of ANOVA, the only 
significant difference in AL was at day 104 
between metronidazole-amoxicillin and long-
term azithromycin groups (p<0.042). 
Furthermore, according to Repeated Measures 
ANOVA, no significant differences existed 
between different groups but the differences 
within each group at different time points was 
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Discussion: 
 
SRP alone is not sufficient for treatment of 
periodontitis and adjunctive therapiessuch as 
topical and systemic antibiotic administration 
are also required (8-10). The effect of different 
antibiotics on periodontitis has been extensively 
studied to find a more efficient monotherapy for 
this purpose to increase patient compliance. In 
our study, three different antibiotic regimens 
(metronidazole plus amoxicillin, short-term 
azithromycin and long-term azithromycin) along 
with mechanical treatment were compared. 
Based on the obtained results, in all three groups 
periodontal parameters improved; but, 
significant differences were found in this respect 
between the metronidazole+ amoxicillin and 
short-term and long-term azithromycin groups. 
In general, significant differences were noted 
between the three groups. It seems that all three 
regimens were effective against chronic 
periodontitis.  
The mean PLI significantly decreased in all 
groups at different time points. The 
metronidazole+ amoxicillin and short-term 
azithromycin groupshad a significant difference 
in this regard with long-term azithromycin. In 
the latter group, greater improvement was 
observed. Considering the fact that similar oral 
health instructions were given to patients and 
they were provided with similar toothbrush and 
toothpaste, this reduction may be due to higher 
attention paid to plaque control due to the longer 
use of antibiotics or the more efficient inhibitory 
effect of long-term azithromycin on biofilm 
formation reducing the formation of bacterial 
plaque. 
In terms of MPBI and GI, significant reductions 
were found in the understudy groups at different 
time points. Significant differences existed in 
this respect between the metronidazole-
amoxicillin group and short-term and long-term 
azithromycin groups and the reductions were 
greater in the latter group.  
PPD also decreased in all groups at different 
time points. The difference in this regard 
between the metronidazole-amoxicillin with 
short- and long-term azithromycin was 
statistically significant bot no such difference 
was noted between the short-term and long-term 
use of azithromycin. Reduction in clinical AL in 
each group at different time points was 
significant as well. But the difference between 
groups was not statistically significant. The only 
significant difference in this regard was noted at 
3 months (the final follow up session) between 
the long-term azithromycin and metronidazole-
amoxicillin groups that indicates the longer 
lasting effect of treatment with long-term 
azithromycin.  
Haffajee et al. in 2008 evaluated different 
periodontal therapies (SRP alone, SRP+ 
azithromycin for 3 days, SRP+metronidazole for 
14 days and SRP+ doxycycline for 3 months) for 
the treatment of chronic periodontitis.  Clinical 
parameters improved in all groups but greater 
improvement was observed in SRP +3 days of 
azithromycin and SRP+14 days of 
metronidazole. Both regimens significantly 
reduced counts of red complex species at 2 
weeks. Percentage of resistant species 
significantly increased in all treatment groups at 
12 months (10). Smith et al. in 2002 performed 
3 sessions of SRP at 0, 1 and 2 weeks. At 2 
weeks, patients were assigned to two groups of 
azithromycin alone for 3 days and placebo. At 
22 weeks, PPD and BOP significantly decreased 
in azithromycin group compared to SRP alone. 
This reduction was especially significant in areas 
with pockets deeper than 5 mm (8). In a study by 
Hass et al. in 2008 two groups of periodontitis 
patients receiving SRP+ placebo and SRP+ 
single dose azithromycin were compared for 3 
days. The two groups were not significantly 
different in terms of reduction in PI, BOP and 
supra-gingival calculus but the clinical 
attachment level and PPD significantly 
decreased in both groups. These reductions were 
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greater in group 2. Thus, azithromycin 
administration is considered as an effective 
adjunctive therapy (11). No significant 
improvement in BOP and PI parameters in Hass 
et al. study (2008) in comparison to ours may be 
attributed to the longer treatment course with 
azithromycin in our study. 
Some previous studies have yielded results 
similar to ours. Dastoor et al. in 2007 compared 
the efficacy of periodontal surgery+placebo with 
that of periodontal surgery plus azithromycin 
administration for 3 days in smoker moderate 
and severe periodontitis patients and showed that 
in each group, a significant reduction occurred in 
CAL, PPD and BOP in surgical sites but no 
significant difference existed between the two 
groups. However, they concluded that 
azithromycin could be effective for facilitating 
wound repair and reducing gingival 
inflammation and number of bacterial pathogens 
(12). The reason for insignificant reduction in 
CAL, PPD and BOP in the mentioned study may 
be conduction of surgery and selection of 
smoker patients; whereas, smoking was an 
exclusion criterion in our study. Our study 
results demonstrated that long-term 
azithromycin regimen was more effective than 
amoxicillin-metronidazole for treatment of 
chronic periodontitis. Also, patients usually 
prefer monotherapy. In a study by Bartold et al. 
in 2012, it was suggested that azithromycin 
could be effective as an adjunctive therapy for 
treatment of chronic periodontitis (13). 
However, it should be noted that long-term use 
of azithromycin has some drawbacks as well 
including the high cost for patients and risk of 
gastrointestinal side effects. Short-term 
azithromycin has a relatively similar and in 
some cases superior effect than amoxicillin-
metronidazole regimen. Furthermore, patients 
usually prefer monotherapy with lower 
frequency of drug intake per day. Thus, short-





Based on the obtained results, all understudy 
therapeutic regimens were effective for 
treatment of chronic periodontitis but the 
magnitude of improvement was greater in long-
term azithromycin group. 
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